Mission & History

AVAIL was founded in January 2020 as a collaboration focused on the burgeoning...


AVAIL will explore all available artificial intelligence opportunities, effectively implement and evaluate using randomized pragmatic trials, selected options in appropriate applications to further the VUMC mission and pillar goals.


VUMC will be regarded as an industry leader in artificial intelligence integration to augment operational efforts. By improving patient experience, clinical outcomes and resource utilization AVAIL will maximize the individual value presented to all VUMC constituents; most importantly, the patient.


AVAIL will review all initiatives designed to augment the human decision making process with AI or other advanced modeling techniques within the VUMC enterprise.